BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37393194)

  • 1. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
    Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
    Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism].
    Pylina SV; Eremkina AK; Elfimova AR; Gorbacheva AM; Mokrysheva NG
    Probl Endokrinol (Mosk); 2024 Feb; 70(1):81-90. PubMed ID: 38433544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
    Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.
    Eller-Vainicher C; Chiodini I; Battista C; Viti R; Mascia ML; Massironi S; Peracchi M; D'Agruma L; Minisola S; Corbetta S; Cole DE; Spada A; Scillitani A
    J Bone Miner Res; 2009 Aug; 24(8):1404-10. PubMed ID: 19309299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe bone complications of primary hyperparathyroidism in a young patient with the rare verified mutation of
    Eremkina AK; Sazonova DV; Bibik EE; Sheikhova AZ; Khairieva AV; Buklemishev YV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2022 Feb; 68(1):81-93. PubMed ID: 35262299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
    Lourenço DM; Coutinho FL; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
    J Bone Miner Res; 2010 Nov; 25(11):2382-91. PubMed ID: 20499354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    PLoS One; 2016; 11(11):e0166634. PubMed ID: 27846313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism.
    Wang W; Nie M; Jiang Y; Li M; Meng X; Xing X; Wang O; Xia W
    Osteoporos Int; 2020 Jan; 31(1):165-173. PubMed ID: 31642976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predicting the presence of
    Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
    Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
    Silva AM; Vodopivec D; Christakis I; Lyons G; Wei Q; Waguespack SG; Petak SM; Grubbs E; Lee JE; Perrier N
    Surgery; 2017 Jan; 161(1):107-115. PubMed ID: 27842919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
    Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy.
    Burgess JR; David R; Greenaway TM; Parameswaran V; Shepherd JJ
    Arch Surg; 1999 Oct; 134(10):1119-23. PubMed ID: 10522858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1.
    Kann PH; Bartsch D; Langer P; Waldmann J; Hadji P; Pfützner A; Klüsener J
    J Endocrinol Invest; 2012 Jun; 35(6):573-9. PubMed ID: 21791969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Centre Experience in Patients with Primary Hyperparathyroidism: Sporadic, Lithium-associated and in Multiple Endocrine Neoplasia.
    Dillenberger S; Bartsch DK; Maurer E; Kann PH
    Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):693-698. PubMed ID: 31412376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.
    Keutgen XM; Nilubol N; Agarwal S; Welch J; Cochran C; Marx SJ; Weinstein LS; Simonds WF; Kebebew E
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):701-707. PubMed ID: 27464610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.
    Cristina EV; Alberto F
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):861-875. PubMed ID: 30665551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.
    Twigt BA; Scholten A; Valk GD; Rinkes IH; Vriens MR
    Orphanet J Rare Dis; 2013 Apr; 8():50. PubMed ID: 23547958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.